ASX - By Stock
|
AVR |
Re:
AGM 2024 questions - please submit here.
|
|
MactavishNat
|
63 |
17K |
6 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
63
|
17K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
First VIV in Europe! Great outcome.
|
|
MactavishNat
|
32 |
8.0K |
6 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
32
|
8.0K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
AGM 2024 questions - please submit here.
|
|
MactavishNat
|
63 |
17K |
9 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
63
|
17K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Published paper that mentions DurAVR
|
|
MactavishNat
|
14 |
5.1K |
0 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
14
|
5.1K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Strategic Partner around the corner
|
|
MactavishNat
|
2 |
1.2K |
11 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
2
|
1.2K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
MactavishNat
|
43 |
12K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
43
|
12K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Capital Raise
|
|
MactavishNat
|
20 |
7.7K |
20 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
20
|
7.7K
|
20
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
MactavishNat
|
24 |
7.7K |
23 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
24
|
7.7K
|
23
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
MactavishNat
|
24 |
7.7K |
4 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
24
|
7.7K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Preparing for Pivotal Trial
|
|
MactavishNat
|
10 |
2.7K |
2 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
10
|
2.7K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Preparing for Pivotal Trial
|
|
MactavishNat
|
10 |
2.7K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
10
|
2.7K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Change of Director's Interest Notice
|
|
MactavishNat
|
13 |
3.3K |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
13
|
3.3K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Application for quotation of securities - AVR
|
|
MactavishNat
|
21 |
5.2K |
5 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
21
|
5.2K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Updated 30-day DurAVR THV Clinical Data
|
|
MactavishNat
|
27 |
9.2K |
4 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
27
|
9.2K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Updated 30-day DurAVR THV Clinical Data
|
|
MactavishNat
|
27 |
9.2K |
15 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
27
|
9.2K
|
15
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Updated 30-day DurAVR THV Clinical Data
|
|
MactavishNat
|
27 |
9.2K |
4 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
27
|
9.2K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Updated 30-day DurAVR THV Clinical Data
|
|
MactavishNat
|
27 |
9.2K |
11 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
27
|
9.2K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
MactavishNat
|
32 |
11K |
6 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
32
|
11K
|
6
|
|
ASX - By Stock
|
DMP |
Re:
DMP vs. Uber eats
|
|
MactavishNat
|
4 |
1.3K |
0 |
27/01/24 |
27/01/24 |
ASX - By Stock
|
4
|
1.3K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
MactavishNat
|
200 |
56K |
2 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
200
|
56K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
all will be revealed.
|
|
MactavishNat
|
5 |
3.7K |
6 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
5
|
3.7K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
MactavishNat
|
200 |
56K |
9 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
200
|
56K
|
9
|
|
ASX - By Stock
|
APM |
Re:
Ann: APM Executive Team Update
|
|
MactavishNat
|
1 |
940 |
0 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
1
|
940
|
0
|
|
ASX - By Stock
|
WOA |
Re:
Ann: Wide Open Agriculture to raise up to A$7.7m
|
|
MactavishNat
|
8 |
3.0K |
2 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
8
|
3.0K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
AVR late breaking trial presentation at London Valves
|
|
MactavishNat
|
19 |
7.9K |
7 |
13/10/23 |
13/10/23 |
ASX - By Stock
|
19
|
7.9K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Update on Edwards
|
|
MactavishNat
|
11 |
5.2K |
6 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
11
|
5.2K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anteris to Present at Cantor Healthcare Conference
|
|
MactavishNat
|
73 |
26K |
6 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
73
|
26K
|
6
|
|
ASX - By Stock
|
PDN |
Re:
Dividends
|
|
MactavishNat
|
71 |
24K |
8 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
71
|
24K
|
8
|
|
ASX - By Stock
|
PDN |
Re:
Dividends
|
|
MactavishNat
|
71 |
24K |
5 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
71
|
24K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
AVR's IMPLANT - TOTALs to DATE
|
|
MactavishNat
|
9 |
3.6K |
0 |
09/09/23 |
09/09/23 |
ASX - By Stock
|
9
|
3.6K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Eureka report
|
|
MactavishNat
|
56 |
19K |
3 |
02/09/23 |
02/09/23 |
ASX - By Stock
|
56
|
19K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Eureka report
|
|
MactavishNat
|
56 |
19K |
2 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
56
|
19K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Cheap takeover
|
|
MactavishNat
|
38 |
12K |
7 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
38
|
12K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
MactavishNat
|
9 |
3.5K |
6 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
9
|
3.5K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Becoming a substantial holder from MS
|
|
MactavishNat
|
8 |
2.6K |
2 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
8
|
2.6K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Becoming a substantial holder from MUFG
|
|
MactavishNat
|
20 |
7.4K |
6 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
20
|
7.4K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Becoming a substantial holder
|
|
MactavishNat
|
18 |
4.9K |
4 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
18
|
4.9K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: FDA Allows Manufacturing to Begin at Expanded Facility
|
|
MactavishNat
|
7 |
4.4K |
7 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
7
|
4.4K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: FDA Allows Manufacturing to Begin at Expanded Facility
|
|
MactavishNat
|
7 |
4.4K |
6 |
27/03/23 |
27/03/23 |
ASX - By Stock
|
7
|
4.4K
|
6
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Change of Director's Interest Notice
|
|
MactavishNat
|
307 |
96K |
1 |
23/03/23 |
23/03/23 |
ASX - By Stock
|
307
|
96K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Settlement of $35M Capital Raising Transaction
|
|
MactavishNat
|
205 |
65K |
3 |
16/03/23 |
16/03/23 |
ASX - By Stock
|
205
|
65K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Settlement of $35M Capital Raising Transaction
|
|
MactavishNat
|
205 |
65K |
21 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
205
|
65K
|
21
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
MactavishNat
|
53 |
17K |
0 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
53
|
17K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
MactavishNat
|
53 |
17K |
3 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
53
|
17K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
MactavishNat
|
53 |
17K |
3 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
53
|
17K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Proposed $50 Million Capital Facility
|
|
MactavishNat
|
62 |
17K |
1 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
62
|
17K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Proposed $50 Million Capital Facility
|
|
MactavishNat
|
62 |
17K |
2 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
62
|
17K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Proposed $50 Million Capital Facility
|
|
MactavishNat
|
62 |
17K |
7 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
62
|
17K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Proposed $50 Million Capital Facility
|
|
MactavishNat
|
62 |
17K |
14 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
62
|
17K
|
14
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
MactavishNat
|
78 |
26K |
7 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
78
|
26K
|
7
|
|